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Metabolic and molecular insights into an essential role
of nicotinamide phosphoribosyltransferase
Li Q Zhang1, Leon Van Haandel2, Min Xiong1, Peixin Huang1, Daniel P Heruth1, Charlie Bi2, Roger Gaedigk2, Xun Jiang1,3, Ding-You Li4,
Gerald Wyckoff5, Dmitry N Grigoryev6, Li Gao7, Linheng Li8, Min Wu9, J Steven Leeder2 and Shui Qing Ye*,1,10
Nicotinamide phosphoribosyltransferase (NAMPT) is a pleiotropic protein implicated in the pathogenesis of acute respiratory
distress syndrome, aging, cancer, coronary heart diseases, diabetes, nonalcoholic fatty liver disease, obesity, rheumatoid arthritis,
and sepsis. However, the underlying molecular mechanisms of NAMPT in these physiological and pathological processes are not
fully understood. Here, we provide experimental evidence that a Nampt gene homozygous knockout (Nampt− /−) resulted in
lethality at an early stage of mouse embryonic development and death within 5–10 days in adult mice accompanied by a
25.24± 2.22% body weight loss, after the tamoxifen induction of NamptF/F × Cre mice. These results substantiate that Nampt is an
essential gene for life. In Nampt− /− mice versus Nampt+/+ mice, biochemical assays indicated that liver and intestinal tissue NAD
levels were decreased significantly; histological examination showed that mouse intestinal villi were atrophic and disrupted, and
visceral fat was depleted; mass spectrometry detected unusual higher serum polyunsaturated fatty acid containing triglycerides.
RNA-seq analyses of both mouse and human pediatric liver transcriptomes have convergently revealed that NAMPT is involved in
key basic cellular functions such as transcription, translation, cell signaling, and fundamental metabolism. Notably, the expression
of all eight enzymes in the tricarboxylic acid cycle were decreased significantly in the Nampt− /−mice. These findings prompt us to
posit that adult Nampt− /−mouse lethality is a result of a short supply of ATP from compromised intestinal absorption of nutrients
from digested food, which leads to the exhaustion of body fat stores.
Cell Death and Disease (2017) 8, e2705; doi:10.1038/cddis.2017.132; published online 23 March 2017
Nicotinamide phosphoribosyltransferase (NAMPT) was initi-
ally named pre-B-cell colony-enhancing factor (PBEF)1 as it
synergized the pre-B-cell colony-formation activity of stem cell
factor and interleukin 7. NAMPT catalyzes the condensation
of nicotinamide with 5-phosphoribosyl-1-pyrophosphate to
yield nicotinamide mononucleotide, an intermediate in the bio-
synthesis of NAD.2 In 2005, Fukuhara et al.3 reported Nampt
as a Visfatin, which was enriched in visceral fat with insulin-
mimetic function. The list of NAMPT’s physiological roles is
continuously growing. The dysregulation of NAMPT gene has
been implicated in several human diseases.4 However, the
underlying molecular mechanisms are not fully understood.
Loss-of-function experiments reveal the functions of a gene.
The most dramatic phenotype is lethality, defining a gene as
essential.5 Recently, three groups reported that there are
about 2000 core genes essential for life in several types of
human cells.6–8 They also found that the essentiality of some
genes is context-dependent and affects viability in a cell-type-
specific manner.9 It is more logical to establish any essential
gene in an animal model, by exploring the terminal pheno-
types and the various molecular mechanisms underlying
lethality. Themouse has long been regarded as an ideal model
system for this purpose. Conservation between humans
and mice is underscored by strong one-to-one orthologous
relationships between genes of the two species.10 We have
previously reported that the Nampt gene DNA coding
sequence between mouse and human is 96% identical.11
Hence, the homozygous Nampt gene knockout in mice would
offer an attractive model to decipher fully the Nampt gene’s
pleiotropic roles, by probing molecular mechanisms under-
lying lethality in adult mice.
Here, we provide experimental evidence that the Nampt
gene homozygous knockout (Nampt− /−) resulted in mouse
embryonic lethality at an early stage. We also established
Nampt gene conditional knockout mice and found that induced
Nampt− /− adult mice died within 5–10 days, accompanied by
a 25.24± 2.22% body weight loss. These results substantiate
that Nampt is an essential gene in vivo. RNA-seq analyses of
both mouse and human pediatric liver transcriptomes
revealed that Nampt is involved in key basic cellular functions
such as transcription, translation, cell signaling, and funda-
mental metabolism. Particularly, expression of all eight
enzymes in the tricarboxylic acid cycle(TAC) in Nampt− /−
adult mice were decreased significantly, which suggests that
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depletion of cellular ATP energy sources may be the main
culprit of adult Nampt− /− mouse death.
Results
Homozygous Nampt gene knockout mice are embryoni-
cally lethal. To study the biological functions of the Nampt
gene, we established the Nampt gene-trapped mouse model
(Figure 1a). To confirm the mutant ES cell line, RT-PCR
results showed that the cell line only expresses about 50%
Nampt mRNA of the Nampt+/+ wild-type control, and western
blotting demonstrated that cellular Nampt protein in the
Nampt+/− ES cell line is decreased significantly (Figure 1b).
The validated ES cell lines were injected into blastocysts of
pseudopregnant female C57BL/6N mice at the Johns
Hopkins University transgenic mouse core facility to generate
the Nampt+/− knockdown mouse model. To facilitate mouse
genotyping needs, we sequenced the whole region of Nampt
gene intron-7, including the inserted gene-trap cassette
(Supplementary Figure 1), and designed three PCR primers
(two forward and one reverse) to detect Nampt wild-type
(Nampt+/+), Nampt heterozygous (Nampt+/− ), and Nampt
knockout (Nampt− /−) mice as indicated in Figure 1c. Repre-
sentative genotyping images of Nampt+/+, Nampt+/− , and
Nampt− /− mice are presented in Figure 1f. To generate
Nampt− /− knockout mice, Nampt+/− male and female mice
were bred. At embryonic day 11.5, Nampt+/+ and Nampt+/−
embryos both have normal development with 40–45 pairs of
somites, and normal embryo size. Nampt− /− embryos are
much smaller in size, and display unclear abnormal embryo
structure (Figure 1d). To establish the Nampt− /− embryonic
lethality, we performed a β-gal staining of mouse embryos at
8.5 d.p.c. stage, as the inserted gene-trap vector β-Geo can
express β-gal. A representative normal size Nampt+/−
embryo has a diffused brown color staining as in the
Nampt+/+ embryo, while an undeveloped Nampt− /− embryo
shows strong dark blue staining (Figure 1e). These results
corroborate that the Nampt− /− mice are lethal at an early
embryonic stage.
Nampt is an essential gene for adult mouse survival. As
Nampt− /− mice are embryonically lethal, we cannot use
Nampt− /− mice for a complete ‘loss of function’ study and
hence we generated a Nampt conditional knockout mouse
line (NampF/F). The Nampt gene spans over 36.9 kb and
contains 11 exons and 10 introns, thus preventing the
Figure 1 Homozygous Nampt gene knockout mice are embryonically lethal. (a) The schematics of gene-trap strategy to create Nampt knockout mice. Gene-trap cassette
were inserted in Nampt gene intron-7 and the transcription of the ‘trapped’ Nampt gene results in a truncated mRNA that will translate into a Nampt exon 1–7 and β-geo fusion
protein. (b) Phenotypic verification of Nampt gene-trapped embryonic stem (ES) cell line. Phenotypic verifications of an ES cell line (RRR084) with Nampt gene interruption
(Nampt+/− ) were carried out by RT-PCR for NamptmRNA and western blotting for Nampt protein expression. Nampt+/+ represents wild-type ES cell line without a gene-trap vector
insertion. (c) Genotyping strategy. Mouse yolk sac or tail DNA was used for genotyping by PCR. The locations of Nampt gene intron-7 and β-Geo specific primers used for
genotyping and predicted size of the PCR products are shown. (d) Representative mouse embryos at 11.5 d.p.c. Timed pregnancies and embryo collection were carried out as
described in the 'Materials and Methods' section. Mouse embryo images from representative Nampt+/+ , Nampt+/− , and Nampt− /− mice at 11.5 d.p.c. are displayed.
(e) Representative mouse embryos at 8.5 d.p.c. Timed pregnancies and embryo collection were carried out as described in the 'Materials and Methods' section. Mouse embryo
images from representative Nampt+/+, Nampt+/− , and Nampt− /− mice at 8.5 d.p.c. after β-Gal staining are displayed. (f) Representative genotyping images. Mouse genotyping
was done using PCR amplification of genomic DNA isolated from mouse embryonic tissue or yolk sac with either primer pairs 5P and 3P or 5P' and 3P as depicted in c. The PCR
products were subjected to 2% agarose electrophoresis and stained by ethidium bromide
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convenient floxing of its entire gene. We decided to introduce
loxP sites into introns flanking exon 2. A Neo selection
cassette flanked by FRT sites was inserted adjacent of the
loxP site within intron-1 as well (Figure 2a). The Namptflox(Neo)
targeting vector was introduced into mouse embryonic stem
cells (mES), which were then injected into C57BL/6 host
blastocysts to generate chimeric mice (Supplementary
Figure 2). Namptflox(Neo)/+ heterozygous mice were crossed
with the ACTB::FLPe deleter mouse line to remove the PGK-
Neo cassette, which has been reported to interfere with gene
expression (Figure 2a). Namptflox/+ mice were backcrossed
with C57BL/6J wild-type mice for 10 generations before being
Figure 2 Nampt is an essential gene for adult mouse survival. (a) Gene targeting strategy for production of mice for conditional inactivation of Nampt gene. Part of intron-1 of
the Nampt gene was used as 5′ arm, part of intron-2 as 3′ arm, exon 2 floxed, Neo and TK used as positive and negative selection marker, respectively. In the process of
homologous recombination, targeting construct replaced the exon 2 of Nampt gene. Neo was selectively removed by Flipase recombinase. Cre-Lox recombination leads to
Nampt second exon excision. 5′P and 3′P represent mice genotyping PCR primers and the black arrows indicate the location of the primers. (b) Genotyping of Namptf/f and
Nampt− /−mice. Representative images of genotyping of Namptf/f and Nampt− /−mice by PCR amplification of either liver or small intestine tissue DNAs are shown. T, tamoxifen;
V, vehicle. (c) Nampt protein expression in Namptf/f and Nampt− /− mice. Western blotting detecting the Nampt protein expression in mouse liver and small intestine tissues
are shown. Gapdh was included as a loading control. (d) Gross morphology of TMX-treated or control mouse abdominal visceral tissues. After TMX (0.04 mg/kg/day, ip) injection
for 4 days, mice body weight was closely monitored. All the UbcCreERT2; Namptflox/flox mice treated with TMX will loss 20% the body weight within 5 days. Just before mouse
morbid, mouse abdomen were dissected as shown. Black arrow head indicate the visceral adipose tissues in a vehicle control mouse. (e) Statistical analysis of mouse body
weight changes. There are two groups of control mice, Namptf/f treated with vehicle and Nampt+/f treated with TMX, both are compared with Namptf/f mice treated with TMX;
N= 10 for each group. *Po0.01 Nampt− /−versus either Namptf/f or Nampt+/f group. (f) Histology of gastrointestinal track by H&E staining. Amplification, × 100; TMX, tamoxifen;
Veh, vehicle
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considered as a pure C57BL/6 background, and subse-
quently intercrossed to obtain homozygous Namptflox/flox
mice. All the genotypes were confirmed by PCR analysis
(Figure 2b) and tissue expression levels of Nampt protein
were verified by western blotting (Figure 2c). Namptflox/flox
mice were born at a normal Mendelian ratio and were viable
without displaying any obvious defect. To conditionally induce
cre-loxP recombination, Namptflox/flox mice were mated to
UbcCreERT2 mice. After 4-day intraperitoneal administration of
tamoxifen (TMX), Namptflox/flox mice (n=10) displayed rapid
weight loss. These mice became dehydrated, less active
on day 3 after injection and reached 420% weight loss
within 5–10 days before dying (Figure 2e). Dissection of dying
Nampt− /− mice showed fat tissue depletion and intes-
tinal abnormality in TMX-treated UbcCreERT2: Namptflox/flox
mice (Figure 2d). The Nampt protein expression levels
were dramatically reduced in TMX-treated UbcCreERT2:
Namptflox/flox mice after day 5(Figure 2c). Histological exami-
nation revealed that Nampt depletion induced severe intes-
tinal villus atrophy and the disruption of normal architecture
(Figure 2f) compared with the wild-type control mice.
Abnormal serum lipid profile in Nampt− /− mice. To
characterize the rapid catabolism of visceral fat in
Nampt− /− mice, we analyzed the serum lipid content in
these mice (Supplementary Table 1) by UHPLC-qTOF MS
method. Principal component analysis revealed that each
experimental group clustered as a unique entity (Figure 3a).
One hundred forty-one lipids were significantly and differen-
tially expressed among the four experimental groups (Supple-
mentary Table 1 and Supplementary Figure 3). A heatmap of
the top 10 differentially presented lipids is displayed in
Figure 3b. High molecular weight Triacylglyceride (TG) with
long polyunsaturated carbon side chains (~4 or more double
bonds) were more prevalent in the 10 and 20% weight loss
group compared with the control groups (Figure 3c,Supple-
mentary Table 1 and Supplementary Figure 3). Conversely,
TGs with a lower number of side chain carbons and fewer
double bonds were less abundant in the control mice than in
the mice with weight loss, especially the 20% weight loss
group. In contrast to TG levels, phosphatidylcholine lipid (PC)
levels were less abundant in the Nampt knockout mice with
10 and 20% weight loss relative to the tamoxifen and vehicle
Figure 3 Serum lipid profiles in Nampt+/+ and Nampt− /−mice. (a) PCA analysis of mouse serum lipid profiles. PCA score plot is derived from MS spectrum of serum samples
from vehicle control (vehicle •), tamoxifen control (TMX •), 10% weight loss (10% loss •), 20% weight loss (20% loss •), and pooled samples (Pool •). N= 3 per group.
(b) Heatmap of differentially expressed serum lipids in mice. Heatmap of the top five upregulated and the top five downregulated differentially expressed lipids between the Nampt
knockdown (20% weight loss, 10% weight loss) and control (tamoxifen and vehicle) groups is presented. (c) Relative abundance of mouse serum triacylglycerides (TG). Relative
abundance of TG with increased number side chain carbons (⩾64) and double bonds between the four groups is represented. (d) Relative abundance of mouse serum
phosphatidylcholines (PC). Relative abundance of PC with 15 to 22 side chain carbons between the four groups is represented
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control mice (Figure 3d, Supplementary Table 1 and
Supplementary Figure 3).
Liver transcriptome profile in Nampt− /− mice. To com-
prehensively investigate the effect of the Nampt gene
knockout on the mouse liver transcriptome profile, we used
RNA-seq to determine and compare hepatic gene expression
changes between Nampt− /− and wild-type Nampt+/+ mice.
A total 4638 genes with significantly differential expression
(P-valueo0.05) in Nampt− /− mice were identified, of which
2434 genes were upregulated and 2204 genes were down-
regulated (Supplementary Table 2). A total 2443 genes
(52.6%) had 42-fold change (Figure 4a). Most of the
genes (97.5%) were protein-coding genes, 34 genes were
lincRNAs, 19 were antisense RNAs, and 232 genes coded for
transcription factors. GO biological process and KEGG
pathway enrichment for the 4638 genes were calculated
(Supplementary Table 3 and Supplementary Table 4). The
results showed that 476 biological processes and 57 signifi-
cant KEGG pathways were enriched (P-valueo0.05). GO
biological process showed that 1050 genes were involved in
106 metabolic processes and 272 genes were involved in 43
biosynthetic processes. In 91 metabolic processes and 40
biosynthetic processes, there were more downregulated
genes than upregulated genes (Supplementary Table 5).
The examined KEGG pathways include metabolism of
xenobiotics by cytochrome P450, drug metabolism, fatty acid
metabolism, glutathione metabolism, nitrogen metabolism,
and the citrate cycle, glycolysis/gluconeogenesis, and nico-
tinate and nicotinamide metabolism (Supplementary Table 4),
which are pertinent to liver and Nampt functions. These
results suggest that most metabolic and biosynthetic
processes have been slowed down in Nampt− /− mice.
As adult Nampt− /− mice showed the similar intestinal villus
atrophy and damage (Figure 2f) as adult replication protein A
subunit3 (Rpa3, another proven essential gene) knockout mice,
Figure 4 Liver transcription profiles in Nampt− /− mice. (a) Heatmap of 4638 significantly differentially expressed liver genes in Nampt− /− mice versus Nampt+/+ mice. Each
column represents a mouse sample. Each row represents a gene. Red color indicates an increased expression. Blue color indicates a decreased expression. N= 7 for each
group. (b) Expression profile of significantly differentially expressed liver genes in 13-ion-associated transport biological processes of Nampt− /− mice versus Nampt+/+ mice.
Percentage value is derived from the number of significantly differentially expressed expression genes in each process divided by total genes involved in 13-ion-associated
transport processes. (c) Expression profile of significantly differentially expressed liver genes in four ATP-associated metabolic processes of Nampt− /− mice versus Nampt+/+
mice. Percentage value is derived from the number of significantly differentially expressed expression genes in each process divided by total genes involved in four ATP-
associated metabolic processes. (d) Heatmap for significantly differentially expressed genes in citrate cycle in Nampt− /−mice versus Nampt+/+ mice. (e) Heatmap for significantly
differentially expressed genes in glycolysis and gluconeogenesis in Nampt− /−mice versus Nampt+/+ mice. (f) Heatmap for significantly differentially expressed genes in fatty acid
metabolism in Nampt− /− mice versus Nampt+/+ mice. In all heat maps, red color indicates high expression, blue color indicates low expression. N= 7 in each group. The
expression of all genes in (d, e and f) were significantly changed between Nampt− /− and Nampt+/+ (P-valueo0.05)
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wecompared expression levels of the liverRpa3 gene and three
other genes(Trp53, Atr and Mapk7), whose conditional homo-
zygous knockouts caused the death,5,12,13 between Nampt− /−
versus Nampt+/+ mice, to determine whether the Nampt− /−
caused lethality is due to downregulation of these genes. Only
the Rpa3 gene expression was significantly downregulated in
Nampt− /− mice versus Nampt+/+ mice (2.40±0.75 versus
5.19±0.87, Supplementary Figure 4).
As intestinal swelling (Figure 2d), villus atrophy, and
damage (Figure 2f) occurred in Nampt− /− mice, we surveyed
significantly differentially expressed genes in 13-ion-
associated transport processes of Nampt− /− mouse liver
tissues, which may provide information about the gastro-
intestinal absorption or transport of ions and nutrients from the
food supply. As presented in Figure 4b, 8 out of 13-ion-
associated transport processes were downregulated. Further-
more, 47.3% of genes in the whole electron transport chain
(53 genes in total) were downregulated, indicating that the
normal function of the electron transport chain has been
compromised (Supplementary Table 6). In mitochondrial ATP
biosynthesis coupled electron transport, more genes were
inhibited. The same trend was true of three other ATP involved
processes (Figure 4c). Of note is that the expression of 16
enzymes in TCA were downregulated, except Pcx, which
catalyzes the carboxylation of pyruvate to oxaloacetate
involved in gluconeogenesis (Figure 4d).
We further focused on the analysis of those genes involved
in carbohydrate and lipid metabolism (Supplementary
Table 7). Most genes in glycolysis were downregulated, but
most genes in gluconeogenesis were upregulated (Figure 4e).
Expressions of 29 of 32 enzymes involved in fatty acid
metabolism were downregulated (Figure 4f). These findings
suggest that the Nampt gene knockout may result in a
decrease of glucose and fatty acid metabolism and an
augmentation of glucose synthesis by gluconeogenesis in
mouse livers. We also noticed that the expression of the
lipase-encoding genes (Lipc, Lipg), 2, 4-dienoyl CoA reduc-
tase genes (Decr1, Decr2), and the enoyl-CoA isomerase
(Eci1) were all downregulated in Nampt− /− mice compared
with theNampt+/+ control mice. This may explain the increased
accumulation of serum high polyunsaturated fatty acid
containing TGs in Nampt− /− mice compared with the
Nampt+/+ control mice (Figure 3c). To investigate whether
the reduced circulating phosphatidylcholine (PC) levels in
Nampt− /− mice (Figure 3d) might be explained by changes
in transport, we examined the expression profiles for
genes encoding PC transporters in our RNA-seq data
(Supplementary Table 8). The expressions of several PC
transporters, including Abca3, Abcb4, Pcyt1a, and Stard7,
were decreased significantly inNampt− /−mice compared with
the Nampt+/+ mice.
Effect of Nampt gene knockout on NAD metabolism and
NAD-involved gene expression. Nampt is a key enzyme
in the cellular NAD synthesis of a mammalian salvage
pathway from nicotinamide. However, the global effect and
full repertoire of gene pools affected by the Nampt gene
knockout are not fully characterized. The adult Nampt− /−
mice have afforded us the opportunity to realize this goal.
Figure 5a displays that in Nampt− /− mice, expression of
nicotinamide nucleotide adenylyltransferase 1(Nmnat1),
which catalyzes the formation of NAD+ from nicotinamide
mononucleotide (NMN), was decreased significantly. Ecto-
nucleotide pyrophosphatase/phosphodiesterase 3(Enpp3),
which catalyzes the hydrolysis of pyrophosphate bonds in
NAD+ to regenerate NMN, Nudix (nucleoside diphosphate
linked moiety X)-type motif 12 (Nudt12), which cleaves NAD+
to AMP and NMN, and Nicotinamide riboside kinase 1
(Nmrk1), which catalyzes the nicotinamide-β-riboside to form
NMN were all downregulated. Expression of three enzyme
genes, Nt5c2: 5′-nucleotidase, cytosolic II (Nt5c2), 5′-
nucleotidase, cytosolic IIIB (Nt5c3b), and Purine-nucleoside
phosphorylase (Pnp), were all upregulated. Activation of
these genes contributes to the generation of nicotinamide
from NMN. All these interactions led to the decreased
synthesis of NMN and hence NAD. Indeed, we found that
NAD levels in liver tissue and jejunum tissue were decreased
significantly in Nampt− /− mice versus Nampt+/+ mice and
paralleled to their body weight loss. In liver tissues, NAD
levels are significantly lower in 20 and 15% body weight loss
groups than the control group (9.10±1.27 and 11.27± 2.27
versus 13.94± 1.35 pmole/mg tissue protein; Figure 5b). In
jejunum tissue, NAD levels are significantly lower in 20 and
15% body weight loss groups than the control group
(2.66±0.59 and 2.93±0.38 versus 5.06±1.40 pmole/mg
tissue protein). In both tissues, NAD levels are decreased in
5% body weight loss group too.
NAD is a critical cofactor for sirtuin protein deacetylase.
We examined the Nampt gene knockout on the expression
of seven sirtuin genes. RNA-seq revealed that expression
of Sirt3, 4, and 5 in mitochondria were decreased signifi-
cantly while expression of Sirt1 in nuclei was increased
significantly in Nampt− /− mice versus Nampt+/+ mice
(Figure 5d). Sirtuin protein controls mitochondrial function
through the deacetylation of targets that include the FOXO
protein family. We then examined the effect of sirtuin
Figure 5 NAD metabolism and NAD-involved gene expression. (a) NAD synthesis from Nampt catalyzed salvage pathway and its metabolism in Nampt− /− mice. Solid red
arrows indicate gene upregulation while blue arrows indicate gene downregulation. Blue dotted arrows indicate reduced metabolite production. (b) Mouse liver NAD levels. Mouse
liver tissues (30 mg) were homogenized and the supernatants were taken for NAD+/NADH assays as described in the 'Materials and Methods' section using a fluorimetric NAD+/
NADH assay kit; 20, 10, and 5% BW loss groups versus tamoxifen-treated control (cntl) group, respectively (Bar=mean±S.D., each group n= 5; *Po0.05, **Po0.01). BW,
body weight. (c) Mouse jejunum tissue NAD levels. Mouse jejunum tissues (30 mg) were homogenized and the supernatants were taken for NAD+/NADH assays as described in
the 'Materials and Methods' section using a fluorimetric NAD+/NADH assay kit; 20, 10, and 5% BW loss groups versus Tamoxifen-treated control (cntl) group, respectively
(Bar=mean±S.D., each group n= 5; *Po0.05, **Po0.01). BW, body weight. (d) Liver Sirt and Foxo gene expression in both Nampt− /− versus Nampt+/+ mice. RNA-seq was
carried out as described in the 'Materials and Methods' section. Gene expression levels are expressed as mean±S.D. of FPKM in each group. (e) Top 10 function enrichment for
4638 significantly changed genes in Nampt− /− versus Nampt+/+ mice. (f) Schema of possible dying causes in Nampt− /− mice. The explanation is provided in the 'Discussion'
section
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downregulation on the expression status of the liver-
expressed FOXO protein family. Liver Foxo4 gene expression
was inhibited significantly in the Nampt− /− mice (Figure 5d).
Sirtuin–Foxo signalingmay control the expression of a number
of genes. Figure 5e shows that acetylated proteins are one of
the two top affected protein families, accounting for 20% of
4638 significantly differently expressed genes in Nampt− /−
versus Nampt+/+ mice.
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Co-expressed genes of human NAMPT gene in human
prenatal and pediatric livers. To relate what we learned
about potential functions of the Nampt gene in mouse liver to
NAMPT’s role in human liver, we examined the expression
patterns of the NAMPT gene and its co-expressed genes in
human prenatal and pediatric liver from an existing RNA-seq
data set. The goal of this ‘guilt-by-association’ coexpression
relationship analysis was to provide insights into potential
functional roles of NAMPT and associated genes. After birth,
expression of the NAMPT gene was upregulated significantly
(171.98±18.47 FPKM postnatally, n= 52 versus 5.69± 1.34
FPKM prenatally, n=10, Po0.01; Figure 6a). Expression of
NAMPT genes positively correlated with the children’s
development and growth until puberty (Figure 6b). A total
1064 genes displayed the same expression pattern as the
NAMPT gene (Supplementary Table 9). GO biological
process enrichment of these co-expressed genes found that
they are involved in several important processes: transcrip-
tion, translation, regulation of cell death, metabolism, and
noncoding RNA processing (Figure 6c). The top five involved
molecular and cellular functions of these co-expressed genes
include gene expression, cell death and survival, protein
synthesis, cellular functions and maintenance, and molecular
transport (Figure 6d). These results suggest that NAMPT
may have similar roles in these processes and functional
categories.
Discussion
Our study represents the first scientific report, with concrete
experimental evidence in a C57BL/6J mouse model, that
Nampt is an essential gene in vivo. This claim is supported by
Figure 6 Co-expressed genes and pathway analysis of human Nampt gene in human pediatric liver samples (a) Nampt expression levels in prenatal and postnatal pediatric
liver samples. RNA-seq analysis of these samples were carried out as described in the 'Materials and Methods'. Nampt expression levels are presented as FPKM. They were
derived from 10 prenatal samples and 52 postnatal samples with 0–17 ages. (b) Nampt expression levels in prenatal (G0) and four different groups (G1–4) of postnatal pediatric
liver samples. Nampt was expressed with 5.69± 1.34 FPKM in G0 group. Nampt expression in G1 to G4 were 108.26± 35.08 (G1, 0–1 year old, n= 14), 195.06± 29.80
(G2, 1–5 years old, n= 14), 223.11± 46.85 (G3, 6–11 years old, n= 13), and 163.25± 26.65 (G4, 12–17 years old, n= 11). **Po0.01, ***Po0.001. (c) Top five GO biological
process enrichment of co-expressed genes of human Nampt gene in human pediatric liver samples. (d) Top five molecular and cellular functions of co-expressed genes of human
Nampt gene in human pediatric liver samples
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the findings that the Nampt gene homozygous knockout
(Nampt− /−) mice were embryonically lethal and Nampt− /−
adult mice died within 5–10 days with 25.24±2.22% body
weight loss. Although several groups – including ours –
previously noted thatNampt gene homozygous knockout mice
were embryonic lethal, none of them reported physical
evidence.3,14–17 Here, we have presented the morphological
and genotyping evidence of mouse embryos at both 8.5 and
11.5 d.p.c. (Figures 1d and e), clearly demonstrating that
Nampt− /−mouse embryos had significantly smaller sizes and
abnormal gross structures, and died before organogenesis.
This ‘gold standard’ of evidence authenticates that the Nampt
gene is an essential gene in living organisms.
In adult Nampt− /− mice, we found seven phenotypes:
death at 5–10 days after the induction 420% body weight
loss (Figure 2); decreased cell NAD levels of both liver and
intestinal tissues (Figures 5b and c); intestinal swelling
(Figure 2d); atrophic intestinal villi (Figure 2f); visceral fat
depletion (Figure 2d); higher serum TG and lower serum
PC levels (Figure 3). To unravel the molecular underpinnings
of these processes, we utilized RNA-seq18 to profile
mouse liver transcriptomes to gain transcriptional insights
into the essential role of Nampt in living organisms. Several
important themes have emerged. First, 4638 differentially
expressed genes in Nampt− /− mouse livers (Figure 4a
and Supplementary Table 2) affect 476 biological processes
and 57 significant KEGG pathways, corroborating Nampt’s
pleiotropic functions. Second, our study found that liver
tissue and jejunum tissue NAD levels were decreased
significantly in Nampt− /− mice versus Nampt+/+ mice
(Figures 5b and c), confirming Nampt’s key role in cell NAD
synthesis.2,16,19 RNA-seq revealed that inNampt− /−mice, key
enzymes in two other salvage pathways and the de novo
synthesis pathway of NAD synthesis were significantly
decreased. It would be of interest to determine whether
NAMPT directly or indirectly inhibits expression of these
genes. Third, RNA-seq analysis of mouse liver transcriptomes
in Nampt− /− mice versus Nampt+/+ mice have provided a
number of novel insights into the essential role of the Nampt
gene. In Nampt− /− mice, genes encoding acetylated proteins
and genes in gluconeogenesis were upregulated while genes
in glycolysis, lipase and tricarboxylic acid cycle were down-
regulated (Figure 4d). TCA shutdown would decrease ATP
synthesis. Without enough ATP, those ATP-dependent trans-
porters – such as those in intestine involved in nutrient
absorption or transport – would cease to function. RNA-seq
analysis indicated that expression of most ion transporter
genes were inhibited significantly in Nampt− /− mice
(Figure 4b). In addition, ATP is needed to maintain normal
tissue structural integrity. In Nampt− /− mice, the short supply
of ATP may be responsible for disrupted intestinal architecture
and villus atrophy (Figure 2f). This may also be due to the high
rate of cell turnover in this tissue, which makes it more
susceptible to energy deficiency. This could explain why, in
clinical trials of cancer treatment, oral administration of FK866
or CHS828,20,21 which inhibits NAMPT enzymatic activity,
caused unwanted side effects dominated by gastrointestinal
symptoms. It suggests that alternative routes of drug admin-
istration may avoid or minimize gastrointestinal side effects,
and achieve better therapeutic efficacy. Of interest is that we
found that Rpa3 gene expression was decreased by more
than 50% in Nampt− /− mice (Supplementary Figure 4). The
phenotype of disrupted intestinal architecture and villus
atrophy in Nampt− /− mice looks similar to those in Rpa3− /−
mice.5 It remains to be elucidated whether this effect is due to
the direct regulation of the Nampt gene knockout on Rpa3
gene expression.
NAD is a critical cofactor for sirtuin protein deacetylase. In
Nampt− /− mice, expression of mitochondrial Sirt3, Sirt4, and
Sirt 5, especially Sirt3, were all diminished significantly while
nuclear Sirt1 was augmented (Figure 5f), suggesting that
Sirt3, instead of Sirt1, may have a key role in life among seven
sirtuin proteins. This is in line with previous evidence by Yang
et al.22 Sirtuins can regulate transcription by deacetylating
transcription factors such as FOXO family. Among several
common FOXO genes, expression of FOXO4 was inhibited
significantly. The dysregulated Sirt3–Foxo4 axis may set up a
chain of reaction to engender the dysregulation of a number of
genes in Nampt− /−mice, becoming a death axis in Nampt− /−
mice. Based on the transcriptional insights, we sum up a
tentative schema in Figure 5f to explain Nampt− /−-induced
death process. Briefly, the homozygousNampt gene knockout
causes a decrease in cell NAD synthesis, which leads to the
dysregulation of NAD-dependent genes such as those
encoding acetylated proteins including Sirt3–Foxo4 axis
and especially the suppression of eight enzymes in TCA
cycle. The resultant decreased ATP output may adversely
affect other genes including Rpa3, ion and nutrient transpor-
ters, as well as disrupt normal intestinal tissue architecture,
which hinders normal nutrient absorption and transport into
the visceral organs and forces themobilization and exhaustion
of fat storage and all energy sources, culminating in
mouse death.
It should be pointed out that Nampt’s functional roles may
not solely depend on its enzymatic activity on NAD
synthesis.23–25 In Nampt− /− mice, liver and intestinal NAD
levels were only 20–30% lower than those in surviving adult
Nampt+/+ mice. Thus, it is warranted to explore whether the
disruption of non-enzymatic functions of Nampt also has a
critical role in the dying phenotype of adult Nampt− /− mice.
Although most data in this study were derived from mice,
transcriptional insights from the mouse liver transcriptome are
largely confirmed by data derived from co-expressed genes of
the NAMPT gene in human prenatal and pediatric liver
samples (Figures 6a–d and Supplementary Table 9). These
results strongly indicate that our findings are applicable to
human studies. NAMPT has been implicated in the patho-
genesis or therapeutic targets of a number of human diseases
or conditions,4 such as acute respiratory distress syndrome,26
aging,27 cancer,28 coronary artery disease,29 diabetes, non-
alcoholic fatty liver disease and obesity,30 rheumatoid arthritis,
and sepsis.31 Recently, a small chemical molecule, P7C3 and
its derivatives, has been found to exert neuroprotective activity
in animal models of Parkinson’s disease, amyotrophic lateral
sclerosis, and concussive injury.32 This compound was
identified as an allosteric activator of NAMPT.33 Our study
contributes global metabolic and transcriptional insights into
Nampt’s essential roles and also provides potential leads to
Nampt’s pleiotropic physiological functions and pathological
roles applicable to disease in humans.
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Materials and Methods
Generation of Nampt+/− mice and their timed pregnancy. A mouse
(129/Ola) embryonic stem (ES) cell line (RRR084) harboring characterized
insertional mutation in the intron-7 of mouse Nampt gene via gene-trap vector
inactivation was obtained from BayGenomics (http://baygenomics.ucsf.edu), a
consortium of research groups in the San Francisco Bay Area funded as part of the
NHLBI's Programs for Genomic Applications.34 The verified RRR084 clone was
injected into C57BL/6N (NCI) blastocysts to generate chimeras in the Johns
Hopkins University School of Medicine (Baltimore, MD, USA) transgenic facility. The
generated chimeric Nampt+/− mice were genotyped by PCR of their tail DNAs. The
chimeric Nampt+/− mice were backcrossed with C57BL/6J for 10 generations
before their usage. All mice were fed an AIN-76 A diet and water ad libitum. They
were housed under controlled conditions (25± 2 °C; 12 h light–dark periods).
All mouse experiments were conducted in accordance with the NIH guidelines and
were approved by the University of Missouri Kansas City Animal Care and Use
Committee.
The early stages of Nampt gene mutant mouse embryos were obtained by timed
pregnancy after breeding between Nampt+/−male and Nampt+/− female mice. Visual
observation of a vaginal plug in female Nampt+/− mice after the mating was counted
0.5 days post coitum (d.p.c.). Mouse embryos at 8.5 or 11.5 d.p.c. were harvested
and fixed in 4% paraformaldehyde for 24 h. The genotyping of mouse embryos was
done by PCR amplification of yolk sac DNA. Mouse embryos at 8.5 d.p.c. were also
subjected to β-Gal staining.
Generation of Nampt gene exon 2 floxed (NamptF/F) and Nampt− /−
mice. A Nampt gene target vector prepared in our lab, in which the exon 2 of
Nampt gene was floxed, was electroporated into a B6-White Murine ES Cell Line
(cat. no. SCR011, EMD Millipore, Billerica, MA, USA) and injected into C57BL/6J
mouse blastocysts in The Transgenic Animal Core, University of Missouri, Columbia,
USA. The generated chimeric NamptF/F mice were verified by PCR analyses of their
tail DNAs.
Adult Nampt− /− mice were generated by mating NamptF/F mice with B6.Cg-Tg
(CAG-cre/Esr1*)5Amc/J(Stock No:004682, Jax Lab, Bar Harbor, ME, USA) followed
by administering tamoxifen induction.
Histological examination of mouse intestinal tissues. Formalin-
fixed mouse intestinal tissue samples were embedded in paraffin, and 5-micron-
thick sections were cut. Replicate sections were stained with hematoxylin and eosin
(H & E) according to standard methods.
Mass Spec analysis of mouse serum lipid levels. The serum
samples were collected and stored at − 80 °C until analyzed. The samples were
extracted and subjected to the ultra-high performance liquid chromatography – high
resolution mass spectrometry UHPLC-HRMS procedure as outlined by Oliver
Fiehn’s group35 and (http://www.metabolomicsworkbench.org/protocols/getprotocol.
php?file_id= 163). The analysis was conducted on a Waters Acquity UPLC coupled
to a Waters Xevo G2-qTOF (quadrupole time-of-flight) mass spectrometer. The
samples were analyzed in positive electrospray mode, and the data were acquired
using the MSe acquisition format with a scan rate of 2 Hz. High-energy MSe scans
were ramped from 15 eV to 30 eV. A leucine enkaphlin (2 μg/ml) solution was used
as lockspray solution. Data processing, including chromatographic alignment and
peak picking occurred in Progenesis QI 2.0. Potential markers were identified by
matching the molecular ion (5 p.p.m. error) and fragment ions (50 p.p.m. error) to
the lipidblast database using the database search feature within progenesis QI.
Further processing occurred by exporting the data to EZinfo 3.0.
Mouse liver RNA isolation. Total mouse liver RNA was isolated from either
the wild-type mice or Nampt− /− mice using the MirVana kit (cat. no. AM1560,
ThermoFisher Scientific, Grand Island, NY, USA) according to the manufacturer's
instructions.
RNA sequencing of mouse liver transcriptomes. RNA-seq of mouse
liver RNAs was carried out in the Core of Genetic Research, Children’s Mercy,
Kansas City, KS, USA, according to the previously published protocol36 except that
sequencing library from 1 μg total mouse liver RNA of each sample was prepared
using the Illumina TruSeq Stranded Total RNA Sample Prep Kit (cat. No. RS-122-
2201) and 2 × 101 paired-end sequencing of high output run mode was performed
using the HiSeq 1500 instrument. Each sample was sequenced to an average depth
of ~ 63 million reads with 480% of bases above Q30. The resulting base calling
(.bcl) files were converted to FASTQ files using Illumina’s bcl2fastq v2.17.1.14
software. Mapping of RNA-seq reads and transcript assembly and abundance
estimation were conducted using Tuxedo Suite pipeline (TopHat v1.3.0/Bowtie
v0.12.7/Cufflinks v1.0.3) and reported in Fragments Per Kilobase of exon per Million
fragments mapped (FPKM).
Functional analysis of differentially expressed gene lists using
Ingenuity Pathway Analysis. The pathway analysis of differentially
expressed gene lists in Nampt− /− mice were analyzed using DAVID (https://
david.ncifcrf.gov/)37 and Ingenuity Pathway Analysis (IPA, Ingenuity Systems, Inc.,
Redwood City, CA, USA) as we described before.38,39 Briefly, genes with a
significant expression change (Po0.05) in mouse liver expression in Nampt− /−
mice versus wild-type mice were loaded into IPA and they were associated with
various pathways in Ingenuity's Knowledge Base for the analysis. The significance
of the association between the data set and any pathway was measured in two
ways: (i) the ratio of the number of molecules from the data set that map to the
pathway divided by the total number of molecules that map to the pathway, and (ii)
Fisher's exact test was used to calculate a P-value determining the probability that
the association between the genes in the data set and the pathway in IPA is
explained by chance alone. Transcription factor prediction database (DBD)40 and
Database of Essential Genes (DEG)41 were used to annotate mouse transcript
factors and essential genes for differentially expressed gene list.
Human pediatric liver samples and RNA-seq analysis. Forty-eight,
anonymized pediatric liver samples, ages 0 days to 17 years, were received from
the following sources: the NICHD Brain and Tissue Bank at the University
of Maryland (funded by NIH contract HHSN275200900011C, Ref. No. #N01-HD-9-
0011); the Liver Tissue Cell Distribution System (funded by NIH Contract
#N01-DK-7-0004/HHSN267200700004C); and six samples were received
from XenoTech, LLC (Lenexa, KS, USA), to whom we are grateful for their
generous gift of tissue samples. Thirty-four prenatal human liver samples (57–
196 days, post-conception) were received from an additional NICHD-funded tissue
retrieval center, the Central Laboratory for Human Embryology (University of
Washington, Seattle, WA, USA). All tissues were flash frozen and maintained at
− 80 °C before isolation of DNA and RNA. All the samples were from anonymous,
deceased donors, and the use of these tissues was declared as nonhuman subjects
research by the University of Missouri-Kansas City Pediatric Health Sciences
Review Board.
RNA-seq analyses of human pediatric liver samples were carried out as described
above for mouse liver transcriptome analyses.
Measurement of mouse liver and jejunum NAD+/NADH levels.
Mouse liver and jejunum tissues (10–30 mg) were homogenized and the
supernatants were applied for NAD+/NADH assays using a Fluorimetric NAD
+/NADH assay kit (Cat. No. 15263; AAT Bioquest. Inc. Sunnyvale, CA, USA).
Statistical analyses. Statistical analyses were performed using the Sigma
Stat (ver 13.0, Systat Software, Inc., San Jose, CA, USA). Results are expressed as
means± S.D. of more than three samples for each group from at least two
independent experiments. Two group comparisons were done by unpaired t-test.
Three or more group comparisons were carried out using ANOVA followed by a
Holm–Sidak test, Po0.05 was considered statistically significant.
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